Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schuff-Werner

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 25, 1980
[Cholestatic hepatitis following antiarrhythmic propafenone therapy]P Schuff-Werner, D Kaiser
MMW Fortschritte Der Medizin|November 9, 2002
[Current therapy of hypercholesterolemia. How much statin does your patient need?]P Schuff-Werner, P Kohlschein
Medizinische Klinik|January 23, 1976
[Hepatitis BS-antigen and hepatis BS-antibodies in partners of HBSAg-positive patients with chronic liver diseases. A contribution to the contagiousness of hepatitis B]H Henning, P Schuff-Werner
Anaesthesia|December 23, 2003
White cell count and intensive care unit outcome: rethinking the vocabularyM Steiner, P Schuff-Werner
Klinische Wochenschrift|September 15, 1980
[Immune reactions in pseudo-lupus-syndrome. A long-term study (author's transl)]P Schuff-Werner, P A Berg
The American Journal of Cardiology|October 30, 1998
Cardiac-allograft vasculopathy and HELP therapyD M Lane, P Schuff-Werner
Der Internist|March 1, 1981
[The significance of prognosis factors in oncology]G A Nagel, P Schuff-Werner
Immunitat Und Infektion|October 1, 1976
[Humoral and cellular immune phenomena in pseudo-lupus-erythematosus (proceedings)]P Schuff-Werner, P A Berg
The American Journal of Gastroenterology|March 10, 2001
Sustained remission of chronic hepatitis C after a change to human leukocyte interferon-alpha in a difficult-to-treat patient with breakthrough phenomenon associated with antibodies against recombinant interferon-alphaT Berg, U Hopf, P Schuff-Werner
Mycoses|May 1, 1992
Chemiluminescence of polymorphonuclear granulocytes in the presence of selected Candida speciesM Borg-von Zepelin, P Schuff-Werner
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Deutsche Medizinische Wochenschrift (1946)|January 25, 1980
[Cholestatic hepatitis following antiarrhythmic propafenone therapy]P Schuff-Werner, D Kaiser
MMW Fortschritte Der Medizin|November 9, 2002
[Current therapy of hypercholesterolemia. How much statin does your patient need?]P Schuff-Werner, P Kohlschein
Medizinische Klinik|January 23, 1976
[Hepatitis BS-antigen and hepatis BS-antibodies in partners of HBSAg-positive patients with chronic liver diseases. A contribution to the contagiousness of hepatitis B]H Henning, P Schuff-Werner
Anaesthesia|December 23, 2003
White cell count and intensive care unit outcome: rethinking the vocabularyM Steiner, P Schuff-Werner
Klinische Wochenschrift|September 15, 1980
[Immune reactions in pseudo-lupus-syndrome. A long-term study (author's transl)]P Schuff-Werner, P A Berg
The American Journal of Cardiology|October 30, 1998
Cardiac-allograft vasculopathy and HELP therapyD M Lane, P Schuff-Werner
Der Internist|March 1, 1981
[The significance of prognosis factors in oncology]G A Nagel, P Schuff-Werner
Immunitat Und Infektion|October 1, 1976
[Humoral and cellular immune phenomena in pseudo-lupus-erythematosus (proceedings)]P Schuff-Werner, P A Berg
The American Journal of Gastroenterology|March 10, 2001
Sustained remission of chronic hepatitis C after a change to human leukocyte interferon-alpha in a difficult-to-treat patient with breakthrough phenomenon associated with antibodies against recombinant interferon-alphaT Berg, U Hopf, P Schuff-Werner
Mycoses|May 1, 1992
Chemiluminescence of polymorphonuclear granulocytes in the presence of selected Candida speciesM Borg-von Zepelin, P Schuff-Werner
Pageof 10